{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:05:53Z","timestamp":1781791553233,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"MEXT KAKENHI","award":["23592316"],"award-info":[{"award-number":["23592316"]}]},{"name":"MEXT KAKENHI","award":["23590732"],"award-info":[{"award-number":["23590732"]}]},{"name":"MEXT KAKENHI","award":["25861403"],"award-info":[{"award-number":["25861403"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.pbb.2015.01.001","type":"journal-article","created":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T07:31:19Z","timestamp":1420788679000},"page":"46-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Antinociceptive effect of intracerebroventricular administration of glycine transporter-2 inhibitor ALX1393 in rat models of inflammatory and neuropathic pain"],"prefix":"10.1016","volume":"130","author":[{"given":"Yoshihiro","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8394-678X","authenticated-orcid":false,"given":"Koji","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Haranishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadanori","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goh","family":"Obara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeyoshi","family":"Sata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2015.01.001_bb0005","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0306-4522(96)00063-2","article-title":"Direct evidence of an extensive GABAergic innervation of the spinal dorsal horn by fibres descending from the rostral ventromedial medulla","volume":"73","author":"Antal","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2015.01.001_bb0010","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2015.01.001_bb0015","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pain.2009.06.014","article-title":"Prefrontal cortex and spinal cord mediated anti-neuropathy and analgesia induced by sarcosine, a glycine-T1 transporter inhibitor","volume":"145","author":"Centeno","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2015.01.001_bb0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2009.04.052","article-title":"Intracerebroventricular or intrathecal injection of glycine produces analgesia in thermal nociception and chemical nociception via glycine receptors","volume":"614","author":"Cheng","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2015.01.001_bb0025","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.pain.2012.01.016","article-title":"Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia","volume":"153","author":"Cobos","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2015.01.001_bb0030","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.neuroscience.2009.08.045","article-title":"Isovaline causes inhibition by increasing potassium conductance in thalamic neurons","volume":"164","author":"Cooke","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2015.01.001_bb0035","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ejphar.2013.10.046","article-title":"Chlorogenic acid administered intrathecally alleviates mechanical and cold hyperalgesia in a rat neuropathic pain model","volume":"723","author":"Hara","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2015.01.001_bb0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pbb.2014.08.011","article-title":"Effects of intrathecal and intracerebroventricular administration of luteolin in a rat neuropathic pain model","volume":"125","author":"Hara","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2015.01.001_bb0045","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1213\/ANE.0b013e3181c7ebbb","article-title":"The antinociceptive effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 in a rat acute pain model","volume":"110","author":"Haranishi","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pbb.2015.01.001_bb0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2015.01.001_bb0055","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nrd3893","article-title":"Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain","volume":"12","author":"Harvey","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pbb.2015.01.001_bb0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neulet.2008.09.012","article-title":"Differential effects of spinally applied glycine transporter inhibitors on nociception in a rat model of neuropathic pain","volume":"445","author":"Hermanns","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pbb.2015.01.001_bb0065","doi-asserted-by":"crossref","first-page":"e35293","DOI":"10.1371\/journal.pone.0035293","article-title":"Distribution of glycine\/GABA neurons in the ventromedial medulla with descending spinal projections and evidence for an ascending glycine\/GABA projection","volume":"7","author":"Hossaini","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2015.01.001_bb0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/01616412.2000.11741054","article-title":"Long-term intrathecal administration of glycine prevents mechanical hyperalgesia in a rat model of neuropathic pain","volume":"22","author":"Huang","year":"2000","journal-title":"Neurol Res"},{"key":"10.1016\/j.pbb.2015.01.001_bb0075","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1046\/j.1471-4159.1995.64031026.x","article-title":"Localization of glycine neurotransmitter transporter (GLYT2) reveals correlation with the distribution of glycine receptor","volume":"64","author":"Jursky","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2015.01.001_bb0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1242\/jeb.196.1.283","article-title":"Structure, function and brain localization of neurotransmitter transporters","volume":"196","author":"Jursky","year":"1994","journal-title":"J Exp Biol"},{"key":"10.1016\/j.pbb.2015.01.001_bb0085","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1213\/ANE.0b013e318282dda7","article-title":"The antinociceptive effect of SNAP5114, a gamma-aminobutyric acid transporter-3 inhibitor, in rat experimental pain models","volume":"116","author":"Kataoka","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pbb.2015.01.001_bb0090","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1523\/JNEUROSCI.4856-05.2006","article-title":"Direct GABAergic and glycinergic inhibition of the substantia gelatinosa from the rostral ventromedial medulla revealed by in vivo patch-clamp analysis in rats","volume":"26","author":"Kato","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2015.01.001_bb0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1124\/jpet.110.175398","article-title":"Microinjection of glycine into the hypothalamic paraventricular nucleus produces diuresis, natriuresis, and inhibition of central sympathetic outflow","volume":"337","author":"Krowicki","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2015.01.001_bb0100","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1213\/ANE.0b013e3181d27da2","article-title":"Analgesic properties of the novel amino acid, isovaline","volume":"110","author":"MacLeod","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.pbb.2015.01.001_bb0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","article-title":"Descending control of pain","volume":"66","author":"Millan","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pbb.2015.01.001_bb0110","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/bph.12343","article-title":"Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain","volume":"170","author":"Mingorance-Le Meur","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pbb.2015.01.001_bb0115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/jpet.108.136267","article-title":"Spinal antiallodynia action of glycine transporter inhibitors in neuropathic pain models in mice","volume":"326","author":"Morita","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2015.01.001_bb0120","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.pbb.2015.01.001_bb0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1744-8069-3-24","article-title":"Actions of N-arachidonyl-glycine in a rat inflammatory pain model","volume":"3","author":"Succar","year":"2007","journal-title":"Mol Pain"},{"key":"10.1016\/j.pbb.2015.01.001_bb0130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/ALN.0b013e31816c9044","article-title":"Glycine transporter inhibitors as a potential therapeutic strategy for chronic pain with memory impairment","volume":"108","author":"Tanabe","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pbb.2015.01.001_bb0135","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neuron.2007.07.012","article-title":"The cerebral signature for pain perception and its modulation","volume":"55","author":"Tracey","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2015.01.001_bb0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2014.05.006","article-title":"Glycine transport inhibitors for the treatment of pain","volume":"35","author":"Vandenberg","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pbb.2015.01.001_bb0145","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuropharm.2007.05.004","article-title":"Actions of N-arachidonyl-glycine in a rat neuropathic pain model","volume":"54","author":"Vuong","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2015.01.001_bb0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0304-3959(89)90160-7","article-title":"Behavioral and autonomic correlates of the tactile evoked allodynia produced by spinal glycine inhibition: effects of modulatory receptor systems and excitatory amino acid antagonists","volume":"37","author":"Yaksh","year":"1989","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2015.01.001_bb0155","first-page":"685","article-title":"Preclinical models of nociception","volume":"vol I","author":"Yaksh","year":"1997"},{"key":"10.1016\/j.pbb.2015.01.001_bb0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/cne.20349","article-title":"Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice","volume":"482","author":"Zeilhofer","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pbb.2015.01.001_bb0160","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-pharmtox-010611-134636","article-title":"Chronic pain states: pharmacological strategies to restore diminished inhibitory spinal pain control","volume":"52","author":"Zeilhofer","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715000039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715000039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T13:16:20Z","timestamp":1650978980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305715000039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":33,"alternative-id":["S0091305715000039"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2015.01.001","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antinociceptive effect of intracerebroventricular administration of glycine transporter-2 inhibitor ALX1393 in rat models of inflammatory and neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2015.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}